Skip to Content

MCR 314 (Lamivudine 300 mg)

Pill with imprint MCR 314 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Appco Pharma LLC.

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MCR 314

Lamivudine 300 mg MCR 314

Lamivudine

Imprint
MCR 314
Strength
300 mg
Color
Gray
Size
17.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Appco Pharma LLC
National Drug Code (NDC)
55801-0314
Inactive Ingredients
ferric oxide red, hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.